P614: The utility as a biomarker of faecal calprotectin for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis treatment in patients with ulcerative colitis
ECCO '19 Copenhagen
2019
P615: Rescue infliximab for acute severe colitis: a single-centre experience
ECCO '19 Copenhagen
2019
P616: Ustekinumab for refractory paediatric Crohn’s disease: experience from two UK tertiary referral centres
ECCO '19 Copenhagen
2019
P617: Evaluation of subclinical myocardial damage in patients with inflammatory bowel disease on treatment with biologics
ECCO '19 Copenhagen
2019
P618: Vedolizumab acute infusion reactions in inflammatory bowel disease patients: results of a multi-centre retrospective observational cohort study
ECCO '19 Copenhagen
2019
P619: Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
ECCO '19 Copenhagen
2019
P620: Stapled end-to-side vs. side-to-side anastomosis after ileocecectomy for Crohn’s disease: a propensity score-matched analysis
ECCO '19 Copenhagen
2019
P621: Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE study
ECCO '19 Copenhagen
2019
P622: Child outcome in IBD pregnancy: early vs. late discontinuation of IFX therapy
ECCO '19 Copenhagen
2019
P623: Colorectal cancer, colectomy rates and inflammatory bowel disease activity following liver transplantation in primary sclerosing cholangitis: a systematic review and meta-analysis
ECCO '19 Copenhagen
2019
P624: Factors that may influence the development of anti-drug antibodies to adalimumab
ECCO '19 Copenhagen
2019
P625: Head-to-head comparison of three stool calprotectin tests for home use
ECCO '19 Copenhagen
2019
P626: Higher discontinuation rates of anti-TNF therapy in elderly IBD patients compared with a younger age group: results from a prospective registry
ECCO '19 Copenhagen
2019
P627: Stopping anti-tumour necrosis factor (TNF) therapy in patients with perianal Crohn’s disease: Results from a population-based study
ECCO '19 Copenhagen
2019
P628: Long-term outcomes with transmural healing vs. mucosal healing in Crohn’s disease: time for new treatment goals ?
ECCO '19 Copenhagen
2019
P629: The initial trough concentration at 36 h after starting tacrolimus is important for the personalised medicine strategy in patients with ulcerative colitis
ECCO '19 Copenhagen
2019
P630: A non-inferiority randomised clinical trial of the use of the smartphone-based health applications IBDsmart and IBDoc® in the care of inflammatory bowel disease patients
ECCO '19 Copenhagen
2019
P631: Development and validation of a clinical scoring tool for predicting treatment outcomes with vedolizumab in patients with ulcerative colitis
ECCO '19 Copenhagen
2019